Heart Failure Clinics

Article	Citations
Unusual Forms of Pulmonary Hypertension	30
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	23
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	22
Fabry Disease	18
Genetic Risk Stratification in Arrhythmogenic Left Ventricular Cardiomyopathy	18
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias	17
When all Else Fails, Try This	15
Forthcoming Issues	14
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	14
Changing Landscape of Heart Failure Imaging	14
Preload Reduction Therapies in Heart Failure	13
Contributors	12
Contributors	12
Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications	12
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	12
Arrhythmias in Adult Congenital Heart Disease Heart Failure	11
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure	11
Mitral Regurgitation	11
Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction	11
Genetics of High-Altitude Pulmonary Edema	11
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	10
Contributors	10
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	9
Heart Failure Clinics	9
Copyright	9

Coronary Angiography in the Evaluation of Systolic Heart Failure	8
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	8
What Is New in Risk Assessment in Nuclear Cardiology?	8
Hypertrophic Cardiomyopathy	7
Specific Therapy in Transthyretin Amyloid Cardiomyopathy	7
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	7
Arrythmia-Mediated Valvular Heart Disease	7
Contributors	7
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy	6
Shifting the Epigenetic and Multi-Omic Frontier to Get the Heart in Top Gear	6
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging	6
Guide to Temporary Mechanical Support in Cardiogenic Shock	6
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	6
Contributors	6
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	6
Cardiac Contractility Modulation	6
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	5
Epigenetics of Heart Failure	5
Copyright	5
SGLT2 Inhibitors in Heart Failure	5
Evolving Strategies in Cardiac Amyloidosis	5
Contributors	5
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	5
Noncoding RNAs in Pulmonary Arterial Hypertension	5
Preface	5
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	4
Contents	4
Adults with Congenital Heart Disease and Transplant	4
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification	4
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	4
Contents	4
Contents	4
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	4
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	4
Contents	4
Copyright	4
Aortic Valvular Stenosis and Heart Failure	3
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	3
SGLT2 Inhibitors and Peripheral Vascular Events	3
Forthcoming Issues	3
Contents	3
Exercise Testing in Pulmonary Hypertension and Heart Failure	3
Risk Factors for Progression in Hypertrophic Cardiomyopathy	3
Remote Monitoring Devices and Heart Failure	3
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	3
The Role of Medical Therapy in Hypertrophic Cardiomyopathy	3
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	3
Novel Non-pharmacological Approaches to Heart Failure	3
Novel Approaches to Sleep Apnea in Heart Failure	2
Contents	2

Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?	2
Genetics of Thoracic and Thoracoabdominal Aortic Dissections and Aneurysms	2
Clinical Use of Biomarkers in Cardiac Amyloidosis	2
Coronary Microvascular Dysfunction	2
Copyright	2
Multiomics Insights into Epigenetic Mechanisms and Their Role as Biomarkers for Acute Coronary Syndrome	2
Adult Congenital Heart Disease	2
Multimodality Imaging in the Evaluation of Hypertrophic Cardiomyopathy	2
Forthcoming Issues	2
Clinical Value of Positron Emission Tomography Myocardial Perfusion Imaging and Blood Flow Quantification	2
Forthcoming Issues	2
Advances in the Therapy of Light Chain Cardiac Amyloidosis	2
Pathophysiology of Cardiac Amyloidosis	2
Latest Updates in Heart Failure Imaging	2
Changing Landscape of Heart Failure Imaging	2
Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification	2
Epigenetic Regulation in Dilated Cardiomyopathy	2
Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure	2
Forthcoming Issues	2
Long-term Complications of Venous Thromboembolism	2
Contributors	2
Copyright	2
Pulmonary Vascular Disease Across the Continuum: From Mechanisms to Precision Care	2
Pediatric and Familial Genetic Arrhythmia Syndromes	1
Multimodality Imaging in Aortic Stenosis	1
Novel PET Applications and Radiotracers for Imaging Cardiovascular Pathophysiology	1
Radionuclide Imaging of Infective Endocarditis	1
Radionuclide Assessment of Sarcoidosis	1
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies	1
Copyright	1
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	1
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk	1
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease	1
Contents	1
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction	1
Contents	1
Copyright	1
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction	1
Nuclear Cardiology	1
Valvular Heart Failure due to Tricuspid Regurgitation	1
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19	1
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension	1
Contents	1
Monitoring for Valve Decrepitude: Surveillance Echo for All at Age 60…?	1
Patient Selection, Referral Framework and Emerging Therapies in Severe Ischemic Heart Failure	1
Challenges in Pulmonary Hypertension	1
Portopulmonary Hypertension	1
Approach to Mitral Regurgitation in Advanced Heart Failure	1
Obesity in Heart Failure with Reduced Ejection Fraction	1
Challenges in Pulmonary Hypertension	1
Cardiac PET Imaging for Coronary Artery Disease and Heart Failure	1
Contributors	1
Pulmonary Vascular Disease: From Bench to Bedside	1
Mechanical Circulatory Support in COVID-19	1
Heart Failure Staging and Indications for Advanced Therapies in Adults with Congenital Heart Disease	1
Venous Thromboembolism in Women and Gender-Diverse Populations	1
Contributors	1
Heart Failure and Embolism	1
Covid-19	0
Copyright	0
Surgical Considerations in Adult Congenital Heart Disease Heart Failure	0
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management	0
Contents	0
Unique Challenges of Adult Congenital Heart Disease in CardioOncology	0
Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction	0
Microscopic Examination of Clots from Percutaneous Mechanical Embolectomies in Pulmonary Embolism	0
SGLT-2 Inhibitors	0
Arrhythmogenic Cardiomyopathy	0
Arrhythmic Stratification of Cardiac Amyloidosis	0
Contents	0
The Evolving Landscape of Hypertrophic Cardiomyopathy	0
Obesity Management for Patients with Coronary Artery Disease and Heart Failure	0
Copyright	0
Forthcoming Issues	0
Copyright	0
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care	0
Epigenomics and Epigenetics in Heart Failure with Preserved Ejection Fraction	0
PET and Cardiac Amyloidosis	0
Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction	0
Navigating the Evolving Landscape of Hypertrophic Cardiomyopathy	0

Advances in the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension	0
Cardiopulmonary Exercise Testing in Research	0
Palliative Care in Adult Congenital Heart Disease–Associated Advanced Heart Disease	0
Cardiac Amyloidosis	0
Cardiac Implantable Electronic Devices in Ischemic Cardiomyopathy	0
Amyloidosis and Amyloidogenesis	0
Evaluation of Coronary Artery Disease and Ischemia by Cardiac Magnetic Resonance Imaging	0
Forthcoming Issues	0
Multimodality Imaging in Hypertrophic Cardiomyopathy	0
Cardiac Amyloidosis	0
Contributors	0
Assessment of Right Ventricle Function and Tricuspid Regurgitation in Heart Failure: Current Advances in Diagnosis and Imaging	0
The Ability of Near-Infrared Spectroscopy to Identify Vulnerable Patients and Plaques: A Systematic Review and Meta-Analysis	0
Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension	0
Nuclear Cardiology in 2023	0
Approach to Ventricular Arrhythmias in Heart Failure	0
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events	0
Cardiopulmonary Exercise Testing in Pulmonary Hypertension	0
Cardiovascular Effects of COVID-19	0
Optimizing Patient Selection, Referral Timing, and Advanced Therapies in Cardiogenic Shock	0
Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects	0
Coronary Artery Disease and Heart Failure	0
Forthcoming Issues	0
The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy	0
Evaluation of Coronary Artery Disease and Ischemia by Echocardiography	0
Contents	0
The Diagnostic and Prognostic Role of Focused Cardiac Ultrasound Performed by Non-cardiologist Specialists in Acute Symptomatic Pulmonary Embolism	0
Epigenetic Therapeutics in Human Heart Failure	0
Interatrial Shunt Devices	0
Targeted Therapies for Microvascular Disease	0
Forthcoming Issues	0
Forthcoming Issues	0
Contributors	0
Contents	0
Genotype-Phenotype Correlations in ATTR Amyloidosis	0
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension	0
Primary Mitral Regurgitation and Heart Failure	0
Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options	0
Valvular Heart Disease and Heart Failure	0
Forthcoming Issues	0
Long-term Complications of Pulmonary Embolism	0
Use and Prognostic Implications of Cardiac Troponin in COVID-19	0
The War Against Heart Failure Hospitalizations	0
Heart Failure Preserved Ejection Fraction in Women	0
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice	0
Surgical Revascularization Decisions in Ischemia and Heart Failure	0
Standard Therapy in Cardiac Amyloidosis	0
Copyright	0
Epidemiology and Definition of Heart Failure in Adult Congenital Heart Disease	0
The Emerging Role of Artificial Intelligence in Valvular Heart Disease	0
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus	0
Copyright	0
Pregnancy and Pulmonary Hypertension	0
Sex-Based Differences in Advanced Heart Failure	0
Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy Across the Lifespan	0
Stress-First Myocardial Perfusion Imaging	0
Contents	0
Tricuspid Regurgitation and Right Heart Failure	0
Contributors	0
Forthcoming Issues	0
Exercise Testing in Elite Athletes	0
Hypertrophic Cardiomyopathy in the Absence of “Hypertrophy”	0
Heart Failure with Reduced Ejection Fraction	0
The Non-invasive Assessment of the Pulmonary Circulation-Right Ventricular Functional Unit	0
Oxygen Therapy in Pulmonary Vascular Disease	0
Contributors	0
SGLT2 Inhibitors Are Lifesavers in Heart Failure	0
Strategy for Exercise Restriction in Hypertrophic Cardiomyopathy	0
PET Imaging for Cardiomyopathy Challenges Simplistic Notions of Ischemia and Viability	0
Positron Emission Tomography Imaging in Vasculitis	0
Heart Failure with Reduced Ejection Fraction and COVID-19, when the Sick Get Sicker	0
Failing with Cyanosis-Heart Failure in End-Stage Unrepaired or Partially Palliated Congenital Heart Disease	0
Contents	0
Copyright	0
Mildly Elevated Pulmonary Hypertension	0
Contributors	0
Contributors	0
How to Start an Invasive Cardiopulmonary Exercise Testing Program	0
Cardiopulmonary Exercise Testing, Rehabilitation, and Exercise Training in Postpulmonary Embolism	0
Contents	0
The Economic Burden of Heart Failure with Reduced Ejection Fraction	0
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension	0
Contents	0
Secondary Mitral Regurgitation and Heart Failure	0
Contents	0
Extracardiac Prothrombotic Effects of COVID-19	0
Pulmonary Hypertension	0
Contributors	0
Copyright	0
Coronary Artery Disease and Heart Failure—Continued Significant Morbidity and Mortality Highlights Need for Comprehensive Evaluation to Individualize Patient Management	0
Contents	0
Viability and Congestive Heart Failure	0
Renoprotective Effects of SGLT2 Inhibitors	0
Navigating Complexity: Contemporary Patient Selection and Advanced Therapies in Heart Failure	0
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis	0